9th Circ. Revives Amgen Drug Rebates Dispute

Law360, New York (November 16, 2009, 12:30 PM EST) -- Amgen Inc. is back on the hook in a contract suit brought by an oncology center over drug rebates, with the U.S. Court of Appeals for the Ninth Circuit reversing an order granting the biotechnology giant's bid to toss the case.

The appeals court on Friday overturned a ruling by the U.S. District Court for the Central District of California to dismiss the case with prejudice for failure to state a claim under California contract law, saying Georgia-based Atlanta Cancer Care PC deserved a chance to...
To view the full article, register now.